United Health Products, Inc.

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze for healthcare and wound care applications. Its primary product is CelluSTAT, a cotton-derived gauze that absorbs wound exudate and helps control bleeding. The company targets human surgical and wound care segments, including external trauma and internal surgical procedures. Its potential customer base includes hospitals, surgery centers, outpatient clinics, emergency medical services, and military medical providers. It also identifies hemodialysis centers, nursing homes, dental offices, and veterinary clinics as prospective clients.

Operationally, the company functions with two full-time consulting personnel and engages external advisers as needed. Executive leadership consists solely of a chief executive officer who also serves as acting chief financial officer. Manufacturing operations rely on contract partners; product manufacturing takes place in Asia, while cutting, packaging, and sterilization are performed in the United States. The provided text does not state the location of the company's headquarters.

Summary of the business section of United Health Products's latest annual report, written by StockData.

“We have fewer than 10 employees and consultants and currently use third-party vendors and service providers for certain product development and regulatory approval activities.”